Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bacillus Calmette-Guérin Vaccination to Prevent Serious Respiratory Tract Infection and Covid-19 in Vulnerable Elderly - an Adaptive randoMized controllEd Trial

NCT04537663 is registered in ClinicalTrials.gov with UMC Utrecht as lead sponsor.

NCT NCT04537663
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04537663 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bacillus Calmette-Guérin Vaccination to Prevent Serious Respiratory Tract Infection and Covid-19 in Vulnerable Elderly - an Adaptive randoMized controllEd Trial
Lead sponsor
UMC Utrecht
Phase
Phase 4
Overall status
Completed
Start date
September 7, 2020
Completion date
July 8, 2021
Enrollment
6,112 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, respiratory tract infections